Competitive Immunoplatform Based on Antibody-Functionalized Magnetic Nanoparticles for Label-Free Cortisol Detection Using Si3N4 Ion-Sensitive Field-Effect Transistors
- 1Institut UTINAM (UMR CNRS 6213), Université Marie et Louis Pasteur, F-25000 Besançon, France.
- 2Institut de Sciences Analytiques (ISA)-UMR 5280, Université Claude Bernard Lyon 1, 5 Rue de la Doua, 69100 Lyon, France.
- 3Institute of Microelectronics of Barcelona (IMB-CNM, CSIC), Campus UAB, 08193 Bellaterra, Spain.
Abstract
Cortisol is a key biomarker involved in the regulation of the hypothalamic–pituitary–adrenal axis and is widely used for assessing physiological stress and endocrine disorders. However, its small molecular size and low charge make its direct detection using field-effect transistor (FET)-based biosensors challenging. In this work, we present a competitive ImmunoFET biosensing platform combining a Si3N4-gated ion-sensitive field-effect transistor (ISFET) with anti-cortisol polyclonal antibody-functionalized magnetic nanoparticles (MNPs) for label-free cortisol detection. The sensing strategy relies on a competitive immunoassay in which cortisol in the sample competes with cortisol immobilized on the ISFET surface for antibody binding sites on the MNPs. Following a 45 min pre-incubation, magnetic separation, and redispersion, the MNPs were brought into contact with the cortisol-functionalized FET and analyzed by electrochemical impedance spectroscopy (EIS). The charge-transfer resistance decreased from 4.012 MΩ to 2.599 MΩ as the cortisol concentration increased from 0.02 to 0.6 ng/mL, confirming the expected competitive behavior. The sensor exhibited a concentration-dependent response over the 0.02–0.6 ng/mL cortisol range, with a limit of detection of 0.006 ng/mL. The platform also showed a stronger response toward cortisol than the investigated non-target biomarkers, including NT-proBNP, TNF-α, and IL-10. Its applicability was further demonstrated in real saliva using the standard addition method, yielding a cortisol concentration of 11.6 ng/mL, compared with an expected value of 10.2 ng/mL, corresponding to a 113.7% recovery. These preliminary results demonstrate the feasibility of the proposed MNP-assisted competitive FET for cortisol detection in biological samples and provide a basis for further development toward point-of-care applications.
Related
- Electrochemical Sensing of Dopamine with a Nafion-Coated Reduced Graphene Oxide/Polypyrrole-Functionalized Magnetic Nanoparticles Composite
- Oligoglycine-functionalized gold nanoparticles: physicochemical characterisation and serum protein interactions
- Thermo-photo catalytic partial oxidation of methane on hematite nanosheets functionalized with silver nanoparticles
- Multifunctional Antibacterial Nanocomposites Based on Graphene Oxide, Graphitic Carbon Nitride, and Cobalt Ferrite Functionalized with an Antimicrobial Polymer Blend and Silver Nanoparticles for Biomedical and Environmental Applications
- Key parameters for reliable biosensing using organic photoelectrochemical transistors: a case study on bilirubin detection
BibTeX
@article{halima2026competitive,
title = {{Competitive Immunoplatform Based on Antibody-Functionalized Magnetic Nanoparticles for Label-Free Cortisol Detection Using Si3N4 Ion-Sensitive Field-Effect Transistors}},
author = {Hamdi Ben Halima and Nadia Zine and Joan Bausells and Abdelhamid Errachid and Nicole Jaffrezic-Renault},
journal = {Biosensors},
year = {2026},
month = oct,
doi = {10.3390/bios16100561},
url = {https://hal.science/hal-05798236v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Competitive Immunoplatform Based on Antibody-Functionalized Magnetic Nanoparticles for Label-Free Cortisol Detection Using Si3N4 Ion-Sensitive Field-Effect Transistors
AU - Hamdi Ben Halima
AU - Nadia Zine
AU - Joan Bausells
AU - Abdelhamid Errachid
AU - Nicole Jaffrezic-Renault
PY - 2026
DA - 2026/10/04
JO - Biosensors
DO - 10.3390/bios16100561
UR - https://hal.science/hal-05798236v1
AB - Cortisol is a key biomarker involved in the regulation of the hypothalamic–pituitary–adrenal axis and is widely used for assessing physiological stress and endocrine disorders. However, its small molecular size and low charge make its direct detection using field-effect transistor (FET)-based biosensors challenging. In this work, we present a competitive ImmunoFET biosensing platform combining a Si3N4-gated ion-sensitive field-effect transistor (ISFET) with anti-cortisol polyclonal antibody-functionalized magnetic nanoparticles (MNPs) for label-free cortisol detection. The sensing strategy relies on a competitive immunoassay in which cortisol in the sample competes with cortisol immobilized on the ISFET surface for antibody binding sites on the MNPs. Following a 45 min pre-incubation, magnetic separation, and redispersion, the MNPs were brought into contact with the cortisol-functionalized FET and analyzed by electrochemical impedance spectroscopy (EIS). The charge-transfer resistance decreased from 4.012 MΩ to 2.599 MΩ as the cortisol concentration increased from 0.02 to 0.6 ng/mL, confirming the expected competitive behavior. The sensor exhibited a concentration-dependent response over the 0.02–0.6 ng/mL cortisol range, with a limit of detection of 0.006 ng/mL. The platform also showed a stronger response toward cortisol than the investigated non-target biomarkers, including NT-proBNP, TNF-α, and IL-10. Its applicability was further demonstrated in real saliva using the standard addition method, yielding a cortisol concentration of 11.6 ng/mL, compared with an expected value of 10.2 ng/mL, corresponding to a 113.7% recovery. These preliminary results demonstrate the feasibility of the proposed MNP-assisted competitive FET for cortisol detection in biological samples and provide a basis for further development toward point-of-care applications.
SN - 2079-6374
ER -